Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer
Xiongyan Wu(Ruijin Hospital), Liping Su(Guangdong Provincial People's Hospital), Jun Yan(University of Louisville), Ying Qu(Chinese Academy of Sciences), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Yingyan Yu(Fujian Medical University), Quan Zhou(Fujian Medical University), Min Yan(Zhengzhou University), Bingya Liu(Shanghai Jiao Tong University), Pu Li(Shanghai Jiao Tong University), Xuehua Chen(Nanjing University of Chinese Medicine), Jianfang Li(Shanghai Jiao Tong University), Beiqin Yu(Ruijin Hospital)
Cited by 93
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400
Exosomes derived from miR‐181‐5p‐modified adipose‐derived mesenchymal stem cells prevent liver fibrosis <i>via</i> autophagy activation
|Journal of Cellular and Molecular Medicine|2017|389
miR-126 functions as a tumour suppressor in human gastric cancer
|Cancer Letters|2010|298
High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance
|Nature Communications|2021|269